Cargando…
Therapeutic Applications
The current treatments offered to patients with chronic respiratory diseases are being re-evaluated based on the loss of potency during long-term treatments or because they only provide significant clinical benefits to a subset of the patient population. For instance, glucocorticoids are considered...
Autores principales: | Tilley, Stephen, Volmer, Jon, Picher, Maryse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120595/ https://www.ncbi.nlm.nih.gov/pubmed/21560050 http://dx.doi.org/10.1007/978-94-007-1217-1_9 |
Ejemplares similares
-
E-NTPDases in human airways: Regulation and relevance for chronic lung diseases
por: Burch, Lauranell H., et al.
Publicado: (2006) -
Animal Models of Airway Diseases
por: Thompson, Linda F., et al.
Publicado: (2011) -
First insights into chlorhexidine retention in the oral cavity after application of different regimens
por: Reda, Bashar, et al.
Publicado: (2021) -
Neuronal Expression of UBQLN2(P497H) Exacerbates TDP-43 Pathology in TDP-43(G348C) Mice through Interaction with Ubiquitin
por: Picher-Martel, Vincent, et al.
Publicado: (2018) -
Structure–activity relationships of dinucleotides: Potent and selective agonists of P2Y receptors
por: Shaver, Sammy R., et al.
Publicado: (2005)